Origins of a Vaccine-Induced, Human Anti-HIV-1 Antibody

被引:0
|
作者
Julien, Jean-Philippe [1 ,2 ,3 ]
机构
[1] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada
[2] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada
来源
EBIOMEDICINE | 2015年 / 2卷 / 07期
关键词
IMMUNE PRESSURE; HIV-1; SITE; TRIAL;
D O I
10.1016/j.ebiom.2015.07.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:632 / +
页数:2
相关论文
共 50 条
  • [11] ENHANCING THE AVIDITY OF A HUMAN RECOMBINANT ANTI-HIV-1 MONOCLONAL-ANTIBODY THROUGH OLIGOMERIZATION
    TSAI, PK
    BURKE, CJ
    IRWIN, JW
    BRUNER, MW
    TUNG, JS
    HOLLIS, GF
    MARK, GE
    KESSLER, JA
    BOOTS, LJ
    CONLEY, AJ
    MIDDAUGH, CR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (07) : 866 - 870
  • [12] PERINATAL HIV-1 INFECTION DESPITE MATERNAL ANTI-HIV-1 NEUTRALIZING ANTIBODY
    KRASINSKI, K
    CAO, YZ
    FIDELIA, A
    BEBENROTH, D
    FRIEDMANKEIN, A
    BORKOWSKY, W
    CLINICAL RESEARCH, 1992, 40 (02): : A381 - A381
  • [13] Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients
    Cooper, Cristine J.
    Metch, Barbara
    Dragavon, Joan
    Coombs, Robert W.
    Baden, Lindsey R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (03): : 275 - 283
  • [14] Induction of Vaccine-Induced HIV Seropositivity in Preventative HIV Vaccine Trials
    Cooper, C. J.
    Wecker, M.
    Djomand, G.
    Metch, B.
    Dragavon, J.
    Coombs, R. W.
    Baden, L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 103 - 103
  • [15] Mechanisms of human immunodeficiency virus type 1 (HIV-1) neutralization: Irreversible inactivation of infectivity by anti-HIV-1 antibody
    McDougal, JS
    Kennedy, MS
    Orloff, SL
    Nicholson, JKA
    Spira, TJ
    JOURNAL OF VIROLOGY, 1996, 70 (08) : 5236 - 5245
  • [16] Anti-HIV-1 Antibodies
    Friedrich, M. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 227 - 227
  • [17] Vaccine-induced antibody responses in patients with carcinoma
    von Mensdorff-Pouilly, Silvia
    EXPERT REVIEW OF VACCINES, 2010, 9 (06) : 579 - 594
  • [18] CDR WALKING MUTAGENESIS FOR THE AFFINITY MATURATION OF A POTENT HUMAN ANTI-HIV-1 ANTIBODY INTO THE PICOMOLAR RANGE
    YANG, WP
    GREEN, K
    PINZSWEENEY, S
    BRIONES, AT
    BURTON, DR
    BARBAS, CF
    JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (03) : 392 - 403
  • [19] Transience of vaccine-induced HIV-1-specific CTL and definition of vaccine "response"
    Jamieson, BD
    Ibarrondo, FJ
    Wong, JT
    Hausner, MA
    Ng, HL
    Fuerst, M
    Price, C
    Shih, R
    Elliott, J
    Hultin, PM
    Hultin, LE
    Anton, PA
    Yang, OO
    VACCINE, 2006, 24 (17) : 3426 - 3431
  • [20] Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine
    Kuwata, T
    Miura, T
    Hayami, M
    TRENDS IN MICROBIOLOGY, 2001, 9 (10) : 475 - 480